Ascendis Pharma Bone Drug Patent Portfolio
Ascendis Pharma Bone owns 1 orange book drug protected by 6 US patents Given below is the list of Ascendis Pharma Bone's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11590207 | Dosage regimen for a controlled-release PTH compound | 28 Sep, 2037 | Active |
| US11759504 | PTH compounds with low peak-to-trough ratios | 28 Sep, 2037 | Active |
| US11857603 | PTH compounds with low peak-to-trough ratios | 28 Sep, 2037 | Active |
| US11890326 | Controlled-release PTH compound | 28 Sep, 2037 | Active |
| US11918628 | Controlled-release PTH compound | 28 Sep, 2037 | Active |
| US8906847 | Prodrug comprising a drug linker conjugate | 30 Apr, 2031 | Active |
Ascendis Pharma Bone's Family Patents
Ascendis Pharma Bone Drug List
Given below is the complete list of Ascendis Pharma Bone's drugs and the patents protecting them.
1. Yorvipath
Yorvipath is protected by 6 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11590207 | Dosage regimen for a controlled-release PTH compound |
28 Sep, 2037
(12 years from now)
| Active |
| US11759504 | PTH compounds with low peak-to-trough ratios |
28 Sep, 2037
(12 years from now)
| Active |
| US11857603 | PTH compounds with low peak-to-trough ratios |
28 Sep, 2037
(12 years from now)
| Active |
| US11890326 | Controlled-release PTH compound |
28 Sep, 2037
(12 years from now)
| Active |
| US11918628 | Controlled-release PTH compound |
28 Sep, 2037
(12 years from now)
| Active |
| US8906847 | Prodrug comprising a drug linker conjugate |
30 Apr, 2031
(6 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Yorvipath's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List